Skip to main content
Figure 6 | BMC Cardiovascular Disorders

Figure 6

From: Early recovery of microvascular perfusion induced by t-PA in combination with abciximab or eptifibatide during postischemic reperfusion

Figure 6

Changes (%) of perfused capillary length (PCL) at baseline and during reperfusion. in the group treated with saline (I/R) and those treated with t-PA (tPA), abiciximab, (AB), eptifibatide (EF), t-PA and t-PA plus abiciximab (tEF) or eptifibatide (tEF), respectively. See text for details. Values are means ± SD; *p < 0.001 I/R, tPA, AB, and EF vs. baseline; °p < 0.05 AB, EF, tAB, and tEF vs. I/R and t-PA; ** p < 0.05 tAB and tEF vs.AB and EF.

Back to article page